Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing - the INSTAR Study

NCT03889743 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT03889743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03889743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing - the INSTAR Study
Lead sponsor
St. Olavs Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
May 8, 2019
Completion date
May 31, 2028
Enrollment
280 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, inflammation